Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
A single amyloidogenic protein is implicated in multiple neurological diseases and capable of generating a number of aggregate “strains” with distinct structures. Among the amyloidogenic proteins, α-synuclein generates multiple patterns of proteinopathies in a group of diseases, such as Parkinson disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). However, the link between specific conformations and distinct pathologies, the key concept of the strain hypothesis, remains elusive. Here we show that in the presence of bacterial endotoxin, lipopolysaccharide (LPS), α-synuclein generated a self-renewable, structurally distinct fibril strain that consistently induced specific patterns of synucleinopathies in mice. These results suggest that amyloid fibrils with self-renewable structures cause distinct types of proteinopathies despite the identical primary structure and that exposure to exogenous pathogens may contribute to the diversity of synucleinopathies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Chronic oral application of P. gingivalis or injection of P. gingivalis LPS results in brain inflammation and neurodegeneration in wild-type mice [70, 89].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [70]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, LPS induces the formation of a distinct type of α-syn fibrils, similar to the pattern of wild-type α-syn fibril induction commonly observed in individuals with PD.239”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [239]
Experimental — accuracy not yet measuredIn the citing paper
“injection of endotoxin into mice induces α-synuclein production and aggregation, as well as loss of dopaminergic neurons in the substantia nigra.”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [70]
In the citing paper
“Endotoxin may also promote the production or aggregation of amyloid β [66–68], tau [68, 69] and α-synuclein [70, 71].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [70]
In the citing paper
“Endotoxin increases α-synuclein production by macrophages [100] and drives α-synuclein fibrillization [70, 71].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Heteronuclear decoupling in rotating solids
Bennett, A. E., Rienstra, C. M., Auger, M., Lakshmi, K. V., & Griffin, R. G. (1995) · The Journal of Chemical Physics · doi:10.1063/1.470372 · Cited by 2,124
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663
Ramped-Amplitude Cross Polarization in Magic-Angle-Spinning NMR
Metz, G., Wu, X. L., & Smith, S. O. (1994) · Journal of Magnetic Resonance, Series A · doi:10.1006/jmra.1994.1208 · Cited by 1,217
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
Peelaerts, W., Bousset, L., Van der Perren, A., Moskalyuk, A., Pulizzi, R., Giugliano, M., Van den Haute, C., Melki, R., & Baekelandt, V. (2015) · Nature · doi:10.1038/nature14547 · Cited by 1,130
Eliezer, D., Kutluay, E., Bussell, R., & Browne, G. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4538 · Cited by 1,090
Self-citationA General Model of Prion Strains and Their Pathogenicity
Collinge, J., & Clarke, A. R. (2007) · Science · doi:10.1126/science.1138718 · Cited by 1,057
– dipolar-assisted rotational resonance in magic-angle spinning NMR
Takegoshi, K., Nakamura, S., & Terao, T. (2001) · Chemical Physics Letters · doi:10.1016/s0009-2614(01)00791-6 · Cited by 1,012
Structural and functional characterization of two alpha-synuclein strains
Bousset, L., Pieri, L., Ruiz-Arlandis, G., Gath, J., Jensen, P. H., Habenstein, B., Madiona, K., Olieric, V., Böckmann, A., Meier, B. H., et al. (2013) · Nature Communications · doi:10.1038/ncomms3575 · Cited by 909
Prion-like spreading of pathological α-synuclein in brain
Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Oikawa, T., Arai, T., Akiyama, H., Mann, D. M. A., & Hasegawa, M. (2013) · Brain · doi:10.1093/brain/awt037 · Cited by 867
Self-citation
Cited by
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
Lipopolysaccharide-induced neuroinflammation as a bridge to understand neurodegeneration
Batista, C. R. A., Gomes, G. F., Candelario-Jalil, E., Fiebich, B. L., & de Oliveira, A. C. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092293 · Cited by 529
“In addition, LPS could also induce conformational changes in α-synuclein protein, which might accelerate the progression of PD [198].”
BackgroundThe endotoxin hypothesis of neurodegeneration
Brown, G. C. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1564-7 · Cited by 457
Meta‐Analysis of Gut Dysbiosis in Parkinson's Disease
Nishiwaki, H., Ito, M., Ishida, T., Hamaguchi, T., Maeda, T., Kashihara, K., Tsuboi, Y., Ueyama, J., Shimamura, T., Mori, H., et al. (2020) · Movement Disorders · doi:10.1002/mds.28119 · Cited by 370
“Fourth, LPS enhances the formation of α-synuclein fibrils in vitro.(30) Fifth, motor deficits and constipation of germ-free mouse models for PD are milder than those for a specific pathogen-free mouse model.”
BackgroundMechanisms and pathology of protein misfolding and aggregation
Louros, N., Schymkowitz, J., & Rousseau, F. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00647-2 · Cited by 250
“Accumulation of endotoxin lipopolysaccharide (LPS) 285 owing to systemic infection is associated with various aggregation-based pathologies 286 , inducing neuroinflammation 287 and morphological changes in amyloid fibrils 288 .”
BackgroundTherapeutic approaches to target alpha-synuclein pathology
Brundin, P., Dave, K. D., & Kordower, J. H. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.10.003 · Cited by 242
Microglia Response During Parkinson’s Disease: Alpha-Synuclein Intervention
Ferreira, S. A., & Romero-Ramos, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00247 · Cited by 216
“Also, the presence or absence of endotoxin in preparations of recombinant a-syn and during fibrilization has also been investigated and shown different effects when approached in vivo (Rutherford et al., 2015; Kim et al., 2016).”
BackgroundBido, S., Muggeo, S., Massimino, L., Marzi, M. J., Giannelli, S. G., Melacini, E., Nannoni, M., Gambarè, D., Bellini, E., Ordazzo, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26519-x · Cited by 190
The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review
Klann, E. M., Dissanayake, U., Gurrala, A., Farrer, M., Shukla, A. W., Ramirez-Zamora, A., Mai, V., & Vedam-Mai, V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.782082 · Cited by 182
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
Peng, C., Gathagan, R. J., & Lee, V. M.-Y. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.07.018 · Cited by 165
Boyd, R. J., Avramopoulos, D., Jantzie, L. L., & McCallion, A. S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02584-x · Cited by 179
“Murine models given LPS injections display increased levels of pro-inflammatory cytokines and microglia activation, loss of DA neurons, and induction of PD phenotypes [181, 182] (Fig.”
BackgroundAlpha-Synuclein Pathology and the Role of the Microbiota in Parkinson’s Disease
Fitzgerald, E., Murphy, S. A., & Martinson, H. A. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00369 · Cited by 163
Metta, V., Leta, V., Mrudula, K. R., Prashanth, L. K., Goyal, V., Borgohain, R., Chung-Faye, G., & Chaudhuri, K. R. (2022) · Journal of Neurology · doi:10.1007/s00415-021-10567-w · Cited by 130
“1 3 brain signaling pathways is plausible [39].”
BackgroundPeelaerts, W., Bousset, L., Baekelandt, V., & Melki, R. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2839-5 · Cited by 134
Infection and Risk of Parkinson’s Disease
Smeyne, R. J., Noyce, A. J., Byrne, M., Savica, R., & Marras, C. (2021) · Journal of Parkinson's Disease · doi:10.3233/jpd-202279 · Cited by 125
Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases
Miller, A. L., Bessho, S., Grando, K. C. M., & Tükel, Ç. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.638867 · Cited by 141
“Endotoxin has also been implicated in the aggregation of a strain of αSyn in PD (171).”
BackgroundModeling α-Synuclein Propagation with Preformed Fibril Injections
Chung, H. K., Ho, H.-A., Pérez-Acuña, D., & Lee, S. (2019) · Journal of Movement Disorders · doi:10.14802/jmd.19046 · Cited by 134
Self-citationGut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment
Salim, S., Ahmad, F. A., Banu, A., & Mohammad, F. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.10.013 · Cited by 132
Structural and Functional Insights into α-Synuclein Fibril Polymorphism
Mehra, S., Gadhe, L. G., Bera, R., Sawner, A. S., & Maji, S. K. (2021) · Biomolecules · doi:10.3390/biom11101419 · Cited by 116
“The appearance of these phase-separated droplets in the lag phase of aggregation kinetics suggests that LLPS might enhance the nucleation events by increasing the local concentration of the protein molecules [315,320].”
BackgroundInfluentialKell, D. B., & Pretorius, E. (2018) · Biological Reviews · doi:10.1111/brv.12407 · Cited by 110
Bhattacharyya, D., Mohite, G. M., Krishnamoorthy, J., Gayen, N., Mehra, S., Navalkar, A., Kotler, S. A., Ratha, B. N., Ghosh, A., Kumar, R., et al. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00733 · Cited by 108
Wijeyekoon, R., Kronenberg‐Versteeg, D., Scott, K. M., Hayat, S., Kuan, W., Evans, J., Breen, D. P., Cummins, G. A., Jones, J., Clatworthy, M. R., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.018 · Cited by 112
Transmission of α-synuclein seeds in neurodegenerative disease: recent developments
Karpowicz, R. J., Trojanowski, J. Q., & Lee, V. M.-Y. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0195-z · Cited by 103
Synucleinopathies: Where we are and where we need to go
Brás, I. C., Dominguez‐Meijide, A., Gerhardt, E., Koss, D. J., Lázaro, D. F., Santos, P. I., Vasili, E., Xylaki, M., & Outeiro, T. F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14965 · Cited by 114
The immunology of Parkinson’s disease
Zhu, B., Yin, D., Zhao, H., & Zhang, L. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00947-3 · Cited by 119
Dasari, A. K. R., Kayed, R., Wi, S., & Lim, K. H. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00215 · Cited by 93
Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
Alam, M. M., Yang, D., Li, X.-Q., Liu, J., Back, T. C., Trivett, A., Karim, B., Barbut, D., Zasloff, M., & Oppenheim, J. J. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110090 · Cited by 91
Venezia, S., Refolo, V., Polissidis, A., Stefanis, L., Wenning, G. K., & Stefanova, N. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0195-7 · Cited by 97
“This finding is supported by recent data reporting that LPS may directly (without the mediatory effect of neuroinflammatory responses) trigger the generation of distinct α-syn fibrils in vitro [50].”
ResultGut Inflammation in Association With Pathogenesis of Parkinson’s Disease
Chen, Q.-Q., Haikal, C., Li, W., & Li, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00218 · Cited by 97
“…intestinal permeability caused by gut inflammation induces the leakage of flora and its metabolites into the body (Berg, 1995; Camilleri et al., 2012; Mu et al., 2017), stimulating the production of pathologic α-syn or proinflammatory cytokines (Chen et al., 2016; Kim et al., 2016; Fukui, 2017).”
BackgroundBellucci, A., Bubacco, L., Longhena, F., Parrella, E., Faustini, G., Porrini, V., Bono, F., Missale, C., & Pizzi, M. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00068 · Cited by 84
Microbiome changes: an indicator of Parkinson’s disease?
Haikal, C., Chen, Q., & Li, J. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-019-0175-7 · Cited by 89
“That the microbiota in the GI system would play a role in synucleinopathies is supported by findings of bacterial substances modulating α-syn aggregation: both lipopolysaccharide [14, 15] and the different subunits of the E.”
BackgroundDe Giorgi, F., Laferrière, F., Zinghirino, F., Faggiani, E., Lends, A., Bertoni, M., Yu, X., Grélard, A., Morvan, E., Habenstein, B., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc4364 · Cited by 79
The Endotoxin Hypothesis of Parkinson's Disease
Brown, G. C., Camacho, M., & Williams‐Gray, C. H. (2023) · Movement Disorders · doi:10.1002/mds.29432 · Cited by 89
“Endotoxin can also induce α-synuclein to fibrillize into novel forms that seed further selfsustaining fibrillization.(76,77) Peripheral endotoxin increased blood–brain barrier permeability and increased uptake of α-synuclein into the brains of mice.”
BackgroundUpregulation of α-synuclein following immune activation: Possible trigger of Parkinson's disease
Kasen, A., Houck, C., Burmeister, A. R., Sha, Q., Brundin, L., & Brundin, P. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105654 · Cited by 78
Involvement of Cellular Prion Protein in α-Synuclein Transport in Neurons
Urrea, L., Segura-Feliu, M., Masuda‐Suzukake, M., Hervera, A., Pedraz, L., García‐Aznar, J. M., Vila, M., Samitier, J., Torrents, E., Ferrer, I., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0451-4 · Cited by 82
“Generated fibrils were tested to insure that they were endotoxin-free to avoid unwanted effects as described [39].”
MethodSelf-citationMechanisms of alpha-synuclein toxicity: An update and outlook
Brás, I. C., Xylaki, M., & Outeiro, T. F. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.005 · Cited by 82
Candelise, N., Schmitz, M., Thüne, K., Cramm, M., Rábano, A., Zafar, S., Stoops, E., Vanderstichele, H., Villar‐Piqué, A., Llorens, F., et al. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-019-0181-9 · Cited by 82
Arylsulfatase A, a genetic modifier of Parkinson’s disease, is an α-synuclein chaperone
Lee, J. S., Kanai, K., Suzuki, M., Kim, W. S., Yoo, H. S., Fu, Y., Kim, D.-K., Jung, B. C., Choi, M.-S., Oh, K. W., et al. (2019) · Brain · doi:10.1093/brain/awz205 · Cited by 69
Self-citationPirolli, N. H., Bentley, W. E., & Jay, S. M. (2021) · Advanced Biology · doi:10.1002/adbi.202000540 · Cited by 76
Pathological role of lipid interaction with α-synuclein in Parkinson's disease
Suzuki, M., Sango, K., Wada, K., & Nagai, Y. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2017.12.014 · Cited by 68
Alpha synuclein in hematopoiesis and immunity
Pei, Y., & Maitta, R. W. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02590 · Cited by 64
“different fibrillary conformations show unique interactions with microglia [24].”
BackgroundThe Peripheral Inflammatory Response to Alpha-Synuclein and Endotoxin in Parkinson's Disease
White, A. J., Wijeyekoon, R., Scott, K. M., Gunawardana, N. P., Hayat, S., Solim, I. H., McMahon, H. T., Barker, R. A., & Williams‐Gray, C. H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00946 · Cited by 62
“Furthermore, endotoxin may influence the conformation of αsynuclein, with different LPS β-sheet content driving alterations in fibril density and changes in associated behavioral phenotypes in animal models (29).”
BackgroundIntermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis
Gadhe, L. G., Sakunthala, A., Mukherjee, S., Gahlot, N., Bera, R., Sawner, A. S., Kadu, P., & Maji, S. K. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2021.106736 · Cited by 58
Tavassoly, O., Yue, J., & Vocadlo, D. J. (2020) · FEBS Journal · doi:10.1111/febs.15349 · Cited by 54
Uriarte Huarte, O., Kyriakis, D., Heurtaux, T., Pires-Afonso, Y., Grzyb, K., Halder, R., Buttini, M., Skupin, A., Mittelbronn, M., & Michelucci, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.639613 · Cited by 52
“Experimentally, peripheral injection of lipopolysaccharide (LPS) in the mouse has been related to neurodegeneration (64) by contributing to the aggregation of different proteins such as asyn (65).”
BackgroundGastrointestinal disorders in Parkinson’s disease and other Lewy body diseases
Hirayama, M., Nishiwaki, H., Hamaguchi, T., & Ohno, K. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00511-2 · Cited by 66
Rani, L., & Mondal, A. C. (2021) · Neuroscience Research · doi:10.1016/j.neures.2021.01.001 · Cited by 50
α-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic Challenges
Arias-Carrión, Ó., Guerra‐Crespo, M., Padilla-Godínez, F. J., Soto-Rojas, L. O., & Manjarrez, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115405 · Cited by 58
Association of Parkinson’s Disease With Microbes and Microbiological Therapy
Chen, Z.-J., Liang, C.-Y., Yang, L.-Q., Ren, S.-M., Xia, Y.-M., Cui, L., Li, X.-F., & Gao, B.-L. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.619354 · Cited by 45
“In a recent study, mice exposed to lipopolysaccharide (LPS) positive bacteria after intracerebral injection of a -SYN produced a unique fibrillary form of a-SYN (Kim et al., 2016).”
BackgroundA Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model
Polinski, N. K. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212847 · Cited by 53
“pathogenicity of the aSyn fibrils themselves [14].”
Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson’s disease
Anis, E., Xie, A., Brundin, L., & Brundin, P. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.11.005 · Cited by 41
Choi, T. S., Lee, J., Han, J. Y., Jung, B. C., Wongkongkathep, P., Loo, J. A., Lee, M. J., & Kim, H. I. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712286 · Cited by 41
Self-citationRegulation of immune-driven pathogenesis in Parkinson’s disease by gut microbiota
Zheng, W., He, R., Yan, Z., Huang, Y., Huang, W., Cai, Z., Su, Y., Liu, S., Deng, Y., Wang, Q., et al. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.009 · Cited by 40
Kim, C., Kwon, S., Iba, M., Spencer, B. J., Rockenstein, E. M., Mante, M., Adame, A., Shin, S. J., Fields, J. A., Rissman, R. A., et al. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00562-6 · Cited by 44
Self-citationRetractedα-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
Hoppe, S. O., Uzunoğlu, G., & Nussbaum-Krammer, C. I. (2021) · Biomolecules · doi:10.3390/biom11070931 · Cited by 40
“Exposure to lipopolysaccharides, bacterial endotoxins, can also induce the formation of a distinct α-Syn conformational strain in vitro, with distinct pathological properties in vivo [125].”
BackgroundThe neuromicrobiology of Parkinson’s disease: A unifying theory
Muñoz, M., Empadinhas, N., & Cardoso, S. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101396 · Cited by 39
“For example, some studies suggest that LPS, a key component of the outer membrane of Gram-negative bacteria, can accelerate Asyn aggregation in vitro (Bhattacharyya et al., 2019; Kim et al., 2016) or even aggravate motor impairment symptoms in an Asyn-overexpressing mouse model (Gorecki et al.”
Kim, D., Hwang, H., Choi, S., Kwon, S. H., Lee, S.-H., Park, J. H., Kim, S., & Ko, H. S. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0538-9 · Cited by 36
“The semi-quantitative grading of p-αSyn pathology of the SNpc was quantified as previously described [16] with minor modification.”
MethodSelf-citationThe Synergy of Aging and LPS Exposure in a Mouse Model of Parkinson’s Disease
Zhao, Y., Qiong-Zhang, Zhang, J., Lou, Z., Zu, H.-B., Wang, Z., Wei-cheng, Z., Kai-Yao, & Xiao, B. (2018) · Aging and Disease · doi:10.14336/ad.2017.1028 · Cited by 38
Tau induces formation of α-synuclein filaments with distinct molecular conformations
Hojjatian, A., Dasari, A. K. R., Sengupta, U., Taylor, D. W., Daneshparvar, N., Yeganeh, F. A., Dillard, L. B., Michael, B. C., Griffin, R. G., Borgnia, M. J., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.091 · Cited by 42
Oral and intestinal dysbiosis in Parkinson's disease
Berthouzoz, E., Lazarević, V., Zekeridou, A., Jiménez, M. C., Debove, I., Aybek, S., Schrenzel, J., Burkhard, P. R., & Fleury, V. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2022.12.010 · Cited by 39
α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
Bigi, A., Cascella, R., & Cecchi, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371345 · Cited by 40
“αS fibrils formed in vitro possess considerably different morphological and biological properties, depending on the various aggregation conditions (Kim et al., 2016; De Giorgi et al., 2020; Shrivastava et al., 2020).”
BackgroundImpact of sex on neuroimmune contributions to Parkinson’s disease
Bourque, M., Morissette, M., Soulet, D., & Paolo, T. D. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110668 · Cited by 37
Tan, L. Y., Yeo, X. Y., Bae, H., Lee, D. P. S., Ho, R., Kim, J. E., Jo, D., & Jung, S. (2021) · Life · doi:10.3390/life11070698 · Cited by 36
The menace within: bacterial amyloids as a trigger for autoimmune and neurodegenerative diseases
Elkins, M., Jain, N., & Tükel, Ç. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102473 · Cited by 35
Gut-Brain axis in Parkinson's disease etiology: The role of lipopolysaccharide
Bhattacharyya, D., & Bhunia, A. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.105029 · Cited by 38
Nargeh, H., Aliabadi, F., Ajami, M., & Pazoki–Toroudi, H. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c00923 · Cited by 33
Amyloid-like oligomerization of AIMP2 contributes to α-synuclein interaction and Lewy-like inclusion
Ham, S., Yun, S. P., Kim, H., Kim, D., Seo, B. A., Kim, H., Shin, J., Dar, M. A., Lee, G. H., Lee, Y. I., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aax0091 · Cited by 33
Differences in the gut microbiome across typical ageing and in Parkinson's disease
Nuzum, N. D., Szymlek‐Gay, E. A., Loke, S., Dawson, S. L., Teo, W., Hendy, A. M., Loughman, A., & Macpherson, H. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109566 · Cited by 33
Boeri, L., Perottoni, S., Izzo, L., Giordano, C., & Albani, D. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002043 · Cited by 28
Urinary Tract Infection in Parkinson’s Disease
Hogg, E., Frank, S., Oft, J., Benway, B., Rashid, M. H., & Lahiri, S. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-213103 · Cited by 36
“aggregation [80, 81] and can contribute to substan-”
Role of cellular prion protein in interneuronal amyloid transmission
del Río, J. A., Ferrer, I., & Gavín, R. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.03.001 · Cited by 34
Vojdani, A., Lerner, A., & Vojdani, E. (2021) · Cells · doi:10.3390/cells10051111 · Cited by 32
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
Fouka, M., Mavroeidi, P., Tsaka, G., & Xilouri, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559791 · Cited by 29
“…this scenario, the central idea is that α-synuclein fibrils behave as strains with discrete biochemical and structural characteristics, into distinct brain regions and cell types (Cremades et al., 2012; Bousset et al., 2013; Kim et al., 2016; Ma et al., 2016; Pieri et al., 2016; Lau et al., 2020).”
Backgroundα-Synuclein Aggregation Intermediates form Fibril Polymorphs with Distinct Prion-like Properties
Mehra, S., Ahlawat, S., Kumar, H., Datta, D., Navalkar, A., Singh, N., Patel, K., Gadhe, L. G., Kadu, P., Kumar, R., et al. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167761 · Cited by 25
Chan, D. G., Ventura, K., Villeneuve, A., Du Bois, P., & Holahan, M. R. (2022) · Journal of Parkinson's Disease · doi:10.3233/jpd-223461 · Cited by 24
Vojdani, A., Vojdani, E., Saidara, E., & Kharrazian, D. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170961 · Cited by 25
Gut-Derived Sterile Inflammation and Parkinson's Disease
Shannon, K. M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.831090 · Cited by 27
“This altered strain has the property of self-renewal and can be used to model synucleinopathy (69).”
BackgroundMethodRevisiting Alpha-Synuclein Pathways to Inflammation
Lyra, P., Machado, V., Rota, S., Chaudhuri, К. R., Botelho, J., & Mendes, J. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087137 · Cited by 26
“Therefore, bacterial exposure may be a driving force in αsynucleinopathies [84,85].”
BackgroundSensing α‐Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration
Brás, I. C., Lopes, L. V., & Outeiro, T. F. (2018) · Movement Disorders · doi:10.1002/mds.27478 · Cited by 25
Brain iron enrichment attenuates α‐synuclein spreading after injection of preformed fibrils
Joppe, K., Tatenhorst, L., Gomes, L. C., Zhang, S., Parvaz, M., Carboni, E., Roser, A., Eldebakey, H., Bähr, M., Vogel‐Mikuš, K., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15461 · Cited by 23
“…α- syn spreading pathology can be observed at 90 dpi and is dependent on the amount of injected PFFs and on the genotype of the used animals (Blumenstock et al., 2017; Kim et al., 2016; Luk, Kehm, Carroll, et al., 2012; Luk, Kehm, Zhang, et al., 2012; Shimozawa et al., 2017; Terada et al., 2018).”
Backgroundα-Synuclein at the Presynaptic Axon Terminal as a Double-Edged Sword
Tan, L. Y., Tang, K. H., Lim, L. Y. Y., Ong, J. X., Park, H., & Jung, S. (2022) · Biomolecules · doi:10.3390/biom12040507 · Cited by 23
Park, S. J., Kim, K. W., & Lee, E. J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00994 · Cited by 28
“LPS drives the formation of a unique, self-replicating α-syn fibril strain that seeds further self-sustaining fibrillization (Kim et al., 2016).”
Mason, D. M., Wang, Y., Bhatia, T. N., Miner, K. M., Trbojevic, S., Stolz, J. F., Luk, K. C., & Leak, R. K. (2019) · Brain Pathology · doi:10.1111/bpa.12718 · Cited by 22
“Kim and colleagues reported a lack of gender differences following infusions of preformed fibrils in the striatum of wild-type mice, supporting the view that the induction site and the route of spread are critical (95).”
BackgroundHaikal, C., Ortigosa-Pascual, L., Najarzadeh, Z., Bernfur, K., Svanbergsson, A., Otzen, D. E., Linse, S. S., & Li, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111594 · Cited by 22
Kim, C., Hovakimyan, A., Zagorski, K., Antonyan, T., Petrushina, I., Davtyan, H., Chailyan, G., Hasselmann, J., Iba, M., Adame, A., et al. (2022) · npj Vaccines · doi:10.1038/s41541-021-00424-2 · Cited by 20
Self-citationRetractedParkinson’s disease: Are gut microbes involved?
Bhattarai, Y., & Kashyap, P. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00058.2020 · Cited by 21
Peelaerts, W., & Baekelandt, V. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01365-5 · Cited by 20
Ozone Environmental Pollution: Relationship between the Intestine and Neurodegenerative Diseases
Rivas-Arancibia, S., Miranda-Martínez, A., Rodríguez-Martínez, E., Hernández-Orozco, E., Valdés‐Fuentes, M., & la Rosa-Sierra, R. D. (2023) · Antioxidants · doi:10.3390/antiox12071323 · Cited by 18
Tanaka, G., Yamanaka, T., Furukawa, Y., Kajimura, N., Mitsuoka, K., & Nukina, N. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.11.200 · Cited by 19
Modulation of Innate Immunity by Amyloidogenic Peptides
Westwell-Roper, C. Y., & Verchere, C. B. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.06.005 · Cited by 18
Pan, B., Shimogawa, M., Zhao, J., Rhoades, E. R., Kashina, A. S., & Petersson, E. J. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c02499 · Cited by 16
Xiromerisiou, G., Marogianni, C., Androutsopoulou, A., Ntavaroukas, P., Mysiris, D. S., & Papoutsopoulou, S. (2023) · Biology · doi:10.3390/biology12010093 · Cited by 22
Amyloids in Site-Specific Autoimmune Reactions and Inflammatory Responses
Huang, Y., Hong, X., Shen, J. X., Geng, L.-J., Pan, Y.-H., Ling, W., & Zhao, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02980 · Cited by 16
Infectious Agents as Potential Drivers of α‐Synucleinopathies
Linard, M., Ravier, A., Mougué, L., Grgurina, I., Boutillier, A., Foubert‐Samier, A., Blanc, F., & Helmer, C. (2022) · Movement Disorders · doi:10.1002/mds.28925 · Cited by 19
Regulation of Pain Perception by Microbiota in Parkinson Disease
Manjarres, Z., Calvo, M., & Pacheco, R. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000674 · Cited by 15
Consonni, A., Miglietti, M., Luca, C. M. G. D., Cazzaniga, F. A., Ciullini, A., Dellarole, I. L., Bufano, G., Fonzo, A. D., Giaccone, G., Baggi, F., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12111579 · Cited by 15
Manole, E., Dumitrescu, L., Niculite, C. M., Popescu, B. O., & Ceafalan, L. C. (2021) · Biocell · doi:10.32604/biocell.2021.013452 · Cited by 15
“It is known that LPS can modulate alpha-synuclein aggregation in vitro and cause many pathological PD-like effects in experimental in vivo models (Kim et al., 2016; Liu and Bing, 2011).”
BackgroundUntwisted α-Synuclein Filaments Formed in the Presence of Lipid Vesicles
Dasari, A. K. R., Dillard, L. B., Yi, S., Viverette, E. G., Hojjatian, A., Sengupta, U., Kayed, R., Taylor, K. A., Borgnia, M. J., & Lim, K. H. (2022) · Biochemistry · doi:10.1021/acs.biochem.2c00283 · Cited by 13
Microbiome Impact on Amyloidogenesis
Curto, J. S., Lopez, A. S., Sanchez, M. C., Tic, I., Fernández, M. R., & de Groot, N. S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.926702 · Cited by 13
Metadata
- Authors
- Kim, C., Lv, G., Lee, J. S., Jung, B. C., Masuda-Suzukake, M., Hong, C.-S., Valera, E., Lee, H.-J., Paik, S. R., Hasegawa, M., Masliah, E., Eliezer, D., & Lee, S.-J.
- Affiliations
- Seoul National University (KR)
- Weill Cornell Medicine (US)
- University of California San Diego (US)
- Konkuk University (KR)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Lee, Seung-Jae
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-08-04
- Volume
- 6
- Issue
- 1
- Pages
- 30891-30891
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4973277
- OpenAlex
- W2486618134
- Cited by
- 138
- References
- 44
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 6 · 2023: 14 · 2022: 22 · 2021: 29 · 2020: 16 · 2019: 15 · 2018: 15 · 2017: 6
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Seoul National University Open Repository (Seoul National University) (submittedVersion)
- Funders
- National Research Foundation
- Fonds National de la Recherche Luxembourg
- National Institute on Aging (R37AG018440, R01AG018440, P50AG005131, R37AG019391, R01AG043384)
- National Institute of Neurological Disorders and Stroke (P30NS057096)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- alpha-synuclein, lipopolysaccharide, bacterial endotoxin, synucleinopathies, Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, protein aggregation, amyloid conformation, neurodegeneration
- MeSH terms
- Amyloid, Animals, Cells, Cultured, Female, Humans, Lipopolysaccharides, Mice, Inbred C57BL, Neurons, Parkinson Disease, Protein Structure, Tertiary, Microglia, Multiple System Atrophy, Lewy Body Disease, Protein Transport, Mice, alpha-Synuclein, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.